The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of targeted therapies (TT) and immunotherapy (IO) on outcomes in patients (pts) with anaplastic thyroid carcinoma (ATC): International data from the Spanish GETNE registry.
 
Jorge Hernando
Speakers' Bureau - Advanced Accelerator Applications; Angelini Pharma; Bayer; Eisai; Ipsen; Novartis; Roche
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Eisai; Ipsen; Novartis; Roche
 
Tiago Nunes
No Relationships to Disclose
 
José Miguel Rodellar
No Relationships to Disclose
 
Alejandro Garcia-Alvarez
Speakers' Bureau - ANGELINI PHARMA ESPAÑA; Eisai; Eisai Europe
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Advanz Pharma; Advanz Pharma; Amgen; Eisai Europe; Ipsen; Pfizer
 
Antia Fernandez
No Relationships to Disclose
 
Germán Iglesias Álvarez
No Relationships to Disclose
 
Isaac Ceballos
No Relationships to Disclose
 
Maria Plana
Honoraria - Eisai Europe; Merck
Travel, Accommodations, Expenses - Eisai Europe
 
Carlos González
No Relationships to Disclose
 
Rosa Bella Cueto
No Relationships to Disclose
 
Maria Luisa Isidro
No Relationships to Disclose
 
Javier Martínez-Trufero
Consulting or Advisory Role - Boehringer Ingelheim Spain; Deciphera; Eisai; GlaxoSmithKline; PharmaMar
Research Funding - Ayala Pharmaceuticals (Inst); BionTech (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Kariopharm Therapeutics (Inst); Lilly (Inst); PharmaMar (Inst); Syneos Health (Inst); SynOX (Inst)
Travel, Accommodations, Expenses - Merck; PharmaMar; PharmaMar; Roche
 
Gloria Marquina
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca Spain; Deciphera; Eisai; Eisai; Eisai; Eisai; Eisai; GlaxoSmithKline; GlaxoSmithKline; Grunenthal; Grunenthal; Ipsen; Lilly; MSD; MSD; MSD Oncology; PharmaMar; Roche; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Eisai; GlaxoSmithKline; Karyopharm Therapeutics; PharmaMar; PharmaMar; Tesaro
Travel, Accommodations, Expenses - Angelini Pharma; Clovis Oncology; Eisai; Eisai; Lilly; Lilly; Lilly; Merck; MSD; MSD; Pfizer; Pfizer; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; PharmaMar; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Tesaro; Tesaro
Other Relationship - GlaxoSmithKline; Tesaro; Tesaro
 
Nieves Martinez Lago
No Relationships to Disclose
 
Guillermo Crespo
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Merck; MSD; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Ipsen; Janssen Oncology; MSD Oncology; Pierre Fabre; Roche
 
Raquel Jimeno
No Relationships to Disclose
 
Isabel Lorenzo-Lorenzo
No Relationships to Disclose
 
Pablo Ayala de Miguel
No Relationships to Disclose
 
Victoria Alcazar
No Relationships to Disclose
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Gilead Sciences (Inst); Ipsen (Inst); Ipsen (Inst); ITM Solucin (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Eisai; Gilead Sciences; Ipsen; Pfizer